Diabetes

This new study investigated the prevalence of and health factors that are associated with depressive symptoms in older adults with diabetes.

A study found that older adults with type 2 diabetes had better physical function and quality of life (QOL) if they had higher psychological resilience.

Loneliness may be a factor that increases the risk of type 2 diabetes but is not mediated by depression or insomnia, according to new study findings.

About 200,000 more children have health insurance since the start of the COVID-19 pandemic; if FDA-approved, bivalent COVID-19 vaccines for younger children are expected to become available by early to mid-October; a trial compared metformin plus sitagliptin, liraglutide, glimepiride, and insulin glargine for maintaining blood glucose levels.

Evidence points to flavorings and preservatives in processed foods as contributors to the beginnings of obesity and type 2 diabetes, according to a recent review.

The rise of telehealth during COVID-19, its limitations, and its uncertain future.

A longitudinal study found that executive function was more predictive than pain for present and future quality of life in older adults with diabetes.

Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.

A recent study found a potential relationship between type 2 diabetes (T2D) macro- and microvascular complications and increased risk of sleep disorders in older Mexican Americans.

A new study has found that diabetes-related deaths in rural areas did not decrease for the period of 1999 to 2019, tripling the mortality gap between urban and rural patients with diabetes.

A prospective cohort study found that women who replaced processed red meat with fatty fish, unprocessed red meat, or vegetables had reduced risks of hypertension and diabetes.

A population-based cohort study of Hispanic Americans found that people who walked more per day had a lower risk of being diagnosed with type 2 diabetes.

While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.

Amazon will shut down its telehealth venture Amazon Care by the end of 2022; youth type 2 diabetes (T2D) diagnoses rose by 77% in the first year of the COVID-19 pandemic; officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment.

According to this systematic review, the best way to optimize diabetes management for patients with both diabetes and intellectual disabilities is supported self-management, which has numerous obstacles to full implementation.

The results suggest that dipeptidyl peptidase-4 (DDP-4) inhibitors, which are widely prescribed in Germany, are not a cost-effective option despite lower drug pricing compared with empagliflozin.

A cross-sectional association was found between plasma prostasin level and risk of diabetes and cancer mortality in patients with high blood glucose levels.

For vision-threatening diseases, such as diabetic macular edema (DME) understanding the economic value of treatments can help identify the direct and indirect benefits of different treatments, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.

HR 5376, or the Inflation Reduction Act, is most significant piece of legislation affecting federal health policy since the passage of the Affordable Care Act in 2010; for Medicare beneficiaries, it caps insulin at $35 a month and includes other pricing reforms.

During the 2022 Congress of the American Society for Preventive Cardiology (ASPC), held in Louisville, Kentucky, Erin D. Michos, MD, MHS, of Johns Hopkins, and Pam R. Taub, MD, of UC San Diego Health, discussed how treatment of diabetes requires going beyond glucose-lowering therapies and including newer medications that offer cardiovascular benefits.

Following a time-restricted eating schedule, limited to a 10-hour window, provides beneficial metabolic effects and the potential for weight loss in patients with type 2 diabetes, according to a new study.

Researchers suggest that annual wellness visits for patients with diabetes lead to earlier diagnoses of complications, preventing amputations and serious consequences.

A recent review found that there were several modifiable and nonmodifiable factors that can affect the treatment adherence of patients with type 2 diabetes (T2D).

A recent study characterized the known association between corticosteroid exposure and type 2 diabetes (T2D), finding risk to be associated with treatment- and patient-related characteristics that can inform prescription of treatment with steroids.